Ubs Asset Management Americas Inc Erasca, Inc. Transaction History
Ubs Asset Management Americas Inc
- $379 Billion
- Q1 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Erasca, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 445,580 shares of ERAS stock, worth $775,309. This represents 0.0% of its overall portfolio holdings.
Number of Shares
445,580
Previous 444,769
0.18%
Holding current value
$775,309
Previous $1.12 Million
45.34%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ERAS
# of Institutions
164Shares Held
222MCall Options Held
20.6KPut Options Held
5.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA22.6MShares$39.3 Million1.95% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.3MShares$30.1 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY16.2MShares$28.2 Million5.36% of portfolio
-
Logos Global Management LP San Francisco, CA13MShares$22.6 Million3.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$22.1 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $213M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...